Compare Becton Dickinson and Co (BDX) vs iShares China Large-Cap ETF (FXI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares China Large-Cap ETF — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $49.41B), while iShares China Large-Cap ETF trades at $35.38. The key difference: Becton Dickinson and Co pays a 2.32% dividend while iShares China Large-Cap ETF pays none, and Becton Dickinson and Co is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| BDX | FXI | |
|---|---|---|
Market Cap | $49.41B | — |
Sector | Health | — |
52-Week High | $185.39 | $41.75 |
52-Week Low | $138.62 | $31.59 |
Enterprise Value | $65.51B | — |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →
